Astellas Pharma Inc. (TYO:4503)
1,352.50
+25.50 (1.92%)
Apr 18, 2025, 3:30 PM JST
Astellas Pharma Employees
Astellas Pharma had 14,754 employees as of March 31, 2024. The number of employees increased by 270 or 1.86% compared to the previous year.
Employees
14,754
Change (1Y)
270
Growth (1Y)
1.86%
Revenue / Employee
126.58M JPY
Profits / Employee
-3.89M JPY
Market Cap
2,421.12B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 7,778 |
Takeda Pharmaceutical Company | 49,281 |
Daiichi Sankyo Company | 18,726 |
HOYA Corporation | 35,702 |
Otsuka Holdings | 35,338 |
Olympus | 28,838 |
Shionogi & | 4,959 |
Sysmex | 10,042 |
Astellas Pharma News
- 1 day ago - Zydus Lifesciences confirms losing US patent case to Astellas in mirabegron litigation - Business Upturn
- 2 days ago - Zydus down 5%, Lupin down nearly 4% as US court orders withdrawal of Myrbetriq drug - Business Upturn
- 25 days ago - Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting - GlobeNewsWire
- 4 weeks ago - Astellas Pharma: Raising New, As Yet Unanswered Questions In Stomach Cancer And Moving Their Pipeline Forward - Seeking Alpha
- 6 weeks ago - Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing - PRNewsWire
- 7 weeks ago - Astellas and MBC BioLabs Announce the Sixth Annual Astellas Future Innovator Prize - PRNewsWire
- 2 months ago - U.S. FDA Approves Expanded Label for Astellas' IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy - PRNewsWire
- 2 months ago - Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo - Benzinga